Erratum: SERPINB3 is associated with longer survival in transgenic mice (Scientific Reports (2013) 3 (3056) DOI: 10.1038/srep03056);SERPINB3 is associated with longer survival in transgenic mice

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Villano, Gianmarco ^a   Ruvoletto, Mariagrazia ^a   Ceolotto, Giulio ^a   Quarta, Santina ^a   Calabrese, Fiorella ^b   Turato, Cristian ^a   Tono, Natascia ^c   Crescenzi, Marika ^a,c   Biasiolo, Alessandra ^a   Cattelan, Arianna ^a   Merkel, Carlo ^a   Avogaro, Angelo ^a   Gatta, Angelo ^a   Pontisso, Patrizia ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Thoracic and Vascular Sciences ^*  (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN; INTERLEUKIN 6; MESSENGER RNA; PROTEIN SHC; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; SHC1 PROTEIN, MOUSE; SQUAMOUS CELL CARCINOMA RELATED ANTIGEN; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TARGET OF RAPAMYCIN KINASE; TUMOR ANTIGEN;

AGING; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CHEMISTRY; FATTY LIVER; FEMALE; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER; LONGEVITY; MALE; METABOLISM; MOUSE; PATHOLOGY; TRANSGENIC MOUSE;

AGING; ANIMALS; ANTIGENS, NEOPLASM; FATTY LIVER; FEMALE; GLYCOGEN; HEP G2 CELLS; HUMANS; INTERLEUKIN-6; LIVER; LONGEVITY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEASE INHIBITORS; RNA, MESSENGER; SERPINS; SHC SIGNALING ADAPTOR PROTEINS; TOR SERINE-THREONINE KINASES;

EID: 84897586027     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04330     Document Type: Erratum

References (44)

1. Silverman, G. A. et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions and a revised nomenclature. J Biol Chem 276, 33293-33296 (2001).
2. Gettins, P. G. Serpin structure, mechanism, and function. Chem Rev 102, 4751-4804 (2002).
3. Silverman, G. A. et al. Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell Mol Life Sci 61, 301-325 (2004).
4. Schick, C. et al. Cross-class inhibition of the cysteine proteinases cathepsins K, L and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 37, 5258-5266 (1998).
5. Masumoto, K. et al. Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. J Biol Chem 278, 45296-45304 (2003).
6. Sakata, Y. et al. The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p1. J Biol Chem 279, 5081-5087 (2004).
7. Kato, H. & Torigoe, T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40, 1621-1628 (1977).
8. Suminami, Y. et al. Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 181, 51-58 (1991).
9. Turato, C. et al. Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? Eur J Cancer 48, 1219-1226 (2012).
10. Chechlinska, M. et al. Squamous cell carcinoma antigen 1 and 2 expression in cultured normal peripheral blood mononuclear cells and in vulvar squamous cell carcinoma. Tumor Biol 31, 559-567 (2010).
11. Takeshima, N. et al. Expression of mRNA of SCC antigen in squamous cells. Tumour Biol 13, 338-342 (1992).
12. Cataltepe, S. et al. Co-expression of squamous cell carcinoma antigen 1 and 2 in normal adult tissues and squamous cell carcinomas. J Histochem Cytochem 48, 113-122 (2000).
13. Pontisso, P. et al. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer 90, 833-837 (2004).
14. Giannelli, G. et al. Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma. Int J Cancer 116, 579-583 (2005).
15. Guido, M. et al. Squamous cell carcinoma antigen in human liver carcinogenesis. J Clin Pathol 61, 445-447 (2008).
16. Beneduce, L. et al. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Cancer 103, 2558-2565 (2005).
17. Pontisso, P. et al. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma. Int J Cancer 119, 735-740 (2006).
18. Biasiolo, A. et al. IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. PLoS One 7, e40658 (2012).
19. Suminami, Y. et al. Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br J Cancer 82, 981-989 (2000).
20. Murakami, A. et al. Squamous cell carcinoma antigen suppresses radiation-induced cell death. Br J Cancer 84, 851-858 (2001).
21. Hashimoto, K. et al. Effect of SCCA1 and SCCA2 on the suppression of TNF-α-induced cell death by impeding the release of mitochondrial cytochrome c in an oral squamous cell carcinoma cell line. Tumor Biol 26, 165-172 (2005).
22. Quarta, S. et al. SERPINB3 induces epithelial-mesenchymal transition. J Path 221, 343-356 (2010).
23. Calabrese, F. et al. Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinico-pathological correlations. Thorax 63, 795-802 (2008).
24. Turato, C. et al. SERPINB3 modulates TGF-beta expression in chronic liver disease. Lab Invest 90, 1016-1023 (2010).
25. Lunardi, F. et al. Overexpression of Serpinb3 promotes epithelial proliferation and lung fibrosis in mice. Lab Invest 9, 945-954 (2011).
26. Kountouras, J., Zavos, C. & Chatzopoulos, D. Apoptosis in hepatocellular carcinoma. Hepatogastroenterology 50, 242-249 (2003).
27. Izuhara, K. et al. Recent progress in understanding the diversity of the human ovserpin/clade B serpin family. Cell Mol Life Sci 65, 2541-2553 (2008).
28. Stoka, V., Turk, V. & Bredesen, D. E. Differential regulation of the intrinsic pathway of apoptosis in brain and liver during ageing. FEBS Letters 580, 3739-3745 (2006).
29. Villano, G. et al. Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. Int J Mol Med 25, 137-143 (2010).
30. Papanicolaou, D. A. et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128, 127-137 (1998).
31. Jin, X. et al. Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology 43, 474-484 (2006).
32. Lee, J. K. et al. Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo study. PLoS One 7, e34218 (2012).
33. Migliaccio, E. et al. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J 16, 706-716 (1997).
34. Giorgio, M. et al. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Bio 8, 722-728 (2007).
35. Oellerich, M. F. & Potente, M. FOXOs and sirtuins in vascular growth, maintenance, and aging. Circ Res 110, 1238-1251 (2012).
36. Sabatini, M. D. mTOR and cancer: insights into a complex relationship. Nature Rev Cancer 6, 729-734 (2006).
37. Bjornsti, M. A. & Houghton, P. J. The TOR pathway: a target for cancer therapy. Nat Rev Cancer 4, 335-348 (2004).
38. Yang, J. D. & Roberts, L. R. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7, 448-458 (2010).
39. Forner, A., Llovet, J. M. & Bruix, J. Hepatocellular carcinoma. Lancet 379, 1245-1255 (2012).
40. Vidalino, L. et al. Serpins, apoptosis and autoimmunity. Autoimm Rev 9, 108-112 (2009).
41. De Falco, S. et al. Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J Biol Chem 39, 36613-36623 (2001).
42. Askew, D. J. et al. Comparative genomic analysis of the clade B serpin cluster at chromosome 18q21: amplification with the mouse squamous cell carcinoma antigen locus. Genomics 84, 176-184 (2004).
43. Sakata, Y. et al. Characterization of novel squamous cell carcinoma antigen-related molecules in mice. Biochem Biophys Res Commun 324, 1340-1345 (2004).
44. -ΔΔCt method. Methods 25, 402-408 (2001).